Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Mar 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)7K$2.86$19K0
Mar 23, 2026Option exercise(M)7K$0.06$3907K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2026Option exercise(M)7K—$0268K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-26-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Serina Therapeutics, Inc.

Build

Ask your agent about SER insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001301120-26-000018"
Ask your agent
Use Arkolith to summarize insider buying and selling at Serina Therapeutics, Inc.
over the last 90 days and cite the filings.